
NASDAQConsumer DefensivePackaged Foods
ข้อมูลล่าสุด
US$1.14
−US$0.005 · -0.44%
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
ราคาปิดก่อนหน้า
US$1.14
−US$0.005 · -0.44%
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
ช่วงราคารายวัน
ปัจจุบัน US$1.14
ช่วง 52 สัปดาห์
ปัจจุบัน US$1.14
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
คะแนน GoAI
ขาย
มูลค่า
47
มูลค่ายุติธรรม
ความเชื่อมั่น
55
ผสม
ความเสี่ยง
57
ความเสี่ยงค่อนข้างสูง
โมเมนตัม
27
กำลังอ่อนตัว
งานวิจัย GoAI ฉบับเต็ม
ดูข้อมูลสนับสนุน ปัจจัยหนุน และความเสี่ยงในเชิงลึก
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
ช่วงราคารายวัน
ปัจจุบัน US$1.14
ช่วง 52 สัปดาห์
ปัจจุบัน US$1.14
อัตรากำไรที่รายงานในช่วงเวลาที่มีอยู่
รายได้
รายได้จากการดำเนินงาน
รายได้สุทธิ
| รายการ (USD) | ปีงบประมาณ 2025 | ปีงบประมาณ 2024 | ปีงบประมาณ 2023 | ปีงบประมาณ 2022 | ปีงบประมาณ 2021 |
|---|---|---|---|---|---|
| รายได้ | 141.35M USD | 129.86M USD | 113.8M USD | 154.02M USD | 170.97M USD |
| ต้นทุนสินค้าขาย | 133.52M USD | 120.57M USD | 106.93M USD | 135.86M USD | 140.46M USD |
| กำไรขั้นต้น | 7.84M USD | 9.29M USD | 6.87M USD | 18.16M USD | 30.51M USD |
| การวิจัยและพัฒนา | 2.3M USD | 1.8M USD | 1.9M USD | 2.1M USD | 2.5M USD |
| การขาย ทั่วไป และธุรการ | 17.3M USD | 16.55M USD | 15.4M USD | 14.87M USD | 16.95M USD |
| ค่าใช้จ่ายในการดำเนินงาน | 16.9M USD | 17.95M USD | 15.4M USD | 13.45M USD | 16.83M USD |
| รายได้ดอกเบี้ย | 50K USD | 168K USD | 176K USD | 33K USD | — |
| ดอกเบี้ยจ่าย | 1.19M USD | 915K USD | 361K USD | 451K USD | 83K USD |
| ค่าเสื่อมราคาและค่าตัดจำหน่าย | 4.71M USD | 4.56M USD | 4.65M USD | 4.25M USD | 4.17M USD |
| รายได้จากการดำเนินงาน | −9.06M USD | −8.66M USD | −8.53M USD | 4.71M USD | 13.68M USD |
| รายได้สุทธิ | −20.7M USD | −13.58M USD | −7.22M USD | 2.52M USD | 10.71M USD |
ข้อเท็จจริงของบริษัทได้รับการปรับปรุง 11 ต.ค. 2569.
ผลประกอบการล่าสุดที่ประกาศ
ผลประกอบการล่าสุดที่ประกาศ
กองทุนซื้อขายแลกเปลี่ยนที่รายงานความเสี่ยงต่อหุ้นนี้
Vanguard Morningstar Total Stock Market ETFVTI335.58K0.00%2.3T USD0.03%US$381.94+0.63%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV162.06K0.00%26.81B USD0.33%US$37.95-0.39%
Vanguard Extended Market ETFVXF109.37K0.00%95.4B USD0.05%US$235+0.80%
U.S. Micro Cap Portfolio ETFDFMC76.87K0.00%7.56B USD0.43%US$57.813+0.20%
Dimensional - US Small Cap ETFDFAS48.61K0.00%33.87B USD0.31%US$78.35+0.32%
EA Bridgeway Omni Small-Cap Value ETFBSVO30K—2.39B USD0.45%US$28.37-0.64%
Dimensional - US Core Equity 2 ETFDFAC19.01K0.00%88.6B USD0.21%US$45.33+0.49%
U.S. Core Equity 1 Portfolio ETF Class SharesDCOR11.77K0.00%45.59B USD0.17%US$84.44+0.44%
Vanguard Morningstar Total Stock Market ETFVTI
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
U.S. Micro Cap Portfolio ETFDFMC
Dimensional - US Small Cap ETFDFAS
EA Bridgeway Omni Small-Cap Value ETFBSVO
Dimensional - US Core Equity 2 ETFDFAC
U.S. Core Equity 1 Portfolio ETF Class SharesDCORเนื้อหาที่สร้างโดย AI และข้อมูลตลาดที่ล่าช้ามีไว้เพื่อให้ข้อมูลและการศึกษาเท่านั้น ไม่ใช่คำแนะนำการลงทุน